Endocrinology, Vol 134, 2011-2017, Copyright © 1994 by Endocrine Society

ARTICLES

Stimulation of glucagon-like peptide-1 secretion by muscarinic agonist in a murine intestinal endocrine cell line

J Abello, F Ye, A Bosshard, C Bernard, JC Cuber and JA Chayvialle
Institut National de la Sante et de la Recherche Medicale U-45, Hopital Edouard Herriot, Lyon, France.

Studies on the cholinergic regulation of intestinal L-cells have been focused on the release of enteroglucagon, but the signal transduction pathways were not defined. These were here investigated by using as index the release of immunoreactive glucagon-like peptide-1 (GLP-1) from the endocrine cell line STC-1, that has been shown to contain proglucagon mRNA transcripts. Abundant GLP-1 immunoreactivity was revealed in STC-1 cells at immunocytochemistry and by RIA. The cell content was 4927 +/- 689 pg/10(6) cells, as measured with antiserum 199D that recognizes specifically the C-terminal amidated forms of GLP- 1. The secretion of GLP-1 over a 2-h incubation period amounted to 1.4 +/- 0.3% of the total GLP-1 cell content and was significantly increased by 10 microM forskolin and 100 nM 12-O-tetradecanoylphorbol 13-acetate to 206% and 574% of control values, respectively. The cholinergic agonist carbachol stimulated GLP-1 secretion in a concentration-dependent manner, maximal release was observed at 1 mM carbachol (228% of the control value). Binding of the muscarinic antagonist [N-methyl-]scopolamine ([3H]NMS) on cell homogenates was time dependent, specific, and saturable. Scatchard analysis revealed one class of receptors (Kd, 14 pM; binding capacity, 20 fmol/mg protein). Carbachol (0.1 microM to 1 mM) dose dependently displaced [3H] NMS binding and increased the intracellular calcium concentration without modification of adenylate cyclase activity. The order of potency of different antagonists, showing a preferential affinity for M1, M2, and M3 muscarinic receptor subtypes, to inhibit [3H]NMS binding, the carbachol-induced increase in intracellular calcium, and carbachol-stimulated GLP-1 secretion, was as follows: atropine (nonselective) > 4-diphenylacetoxy-N-methylpiperidine methiodide (M3) > pirenzepine (M1) > AF-DX 116 (M2). The results of the present study, therefore, demonstrate that secretion of GLP-1 induced by cholinergic agonist depends on muscarinic M3-subtype receptors in the endocrine intestinal cell line STC-1. This system may prove useful to study the cellular mechanisms of GLP-1 secretion.

This article has been cited by other articles:

				G. Tolhurst, F. Reimann, and F. M. Gribble Nutritional regulation of glucagon-like peptide-1 secretion J. Physiol., January 1, 2009; 587(1): 27 - 32. [Abstract] [Full Text] [PDF]

				Z.-L. Chu, C. Carroll, J. Alfonso, V. Gutierrez, H. He, A. Lucman, M. Pedraza, H. Mondala, H. Gao, D. Bagnol, et al. A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release Endocrinology, May 1, 2008; 149(5): 2038 - 2047. [Abstract] [Full Text] [PDF]

				Y. Anini, T. Hansotia, and P. L. Brubaker Muscarinic Receptors Control Postprandial Release of Glucagon-Like Peptide-1: In Vivo and in Vitro Studies in Rats Endocrinology, June 1, 2002; 143(6): 2420 - 2426. [Abstract] [Full Text] [PDF]

				P. Gilon and J.-C. Henquin Mechanisms and Physiological Significance of the Cholinergic Control of Pancreatic {beta}-Cell Function Endocr. Rev., October 1, 2001; 22(5): 565 - 604. [Abstract] [Full Text] [PDF]

				R. A. Reimer, C. Darimont, S. Gremlich, V. Nicolas-Metral, U. T. Ruegg, and K. Mace A Human Cellular Model for Studying the Regulation of Glucagon-Like Peptide-1 Secretion Endocrinology, October 1, 2001; 142(10): 4522 - 4528. [Abstract] [Full Text] [PDF]

				G. Cuche, J. C. Cuber, and C. H. Malbert Ileal short-chain fatty acids inhibit gastric motility by a humoral pathway Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G925 - G930. [Abstract] [Full Text] [PDF]

				J. Dumortier, C. Ratineau, J.-Y. Scoazec, C. Pourreyron, W. Anderson, M.-F. Jacquier, M. Blanc, C. Bernard, C. Bellaton, L. Remy, et al. Site-Specific Epithelial-Mesenchymal Interactions in Digestive Neuroendocrine Tumors : An Experimental in Vivo and inVitro Study Am. J. Pathol., February 1, 2000; 156(2): 671 - 683. [Abstract] [Full Text] [PDF]

				T. J. Kieffer and J. Francis Habener The Glucagon-Like Peptides Endocr. Rev., December 1, 1999; 20(6): 876 - 913. [Abstract] [Full Text]

				A. S. Rocca and P. L. Brubaker Role of the Vagus Nerve in Mediating Proximal Nutrient-Induced Glucagon-Like Peptide-1 Secretion Endocrinology, April 1, 1999; 140(4): 1687 - 1694. [Abstract] [Full Text]

				J. C. Saurin, E. Nemoz-Gaillard, B. Sordat, J. C. Cuber, D. H. Coy, J. Abello, and J. A. Chayvialle Bombesin Stimulates Adhesion, Spreading, Lamellipodia Formation, and Proliferation in the Human Colon Carcinoma Isreco1 Cell Line Cancer Res., February 1, 1999; 59(4): 962 - 967. [Abstract] [Full Text] [PDF]

				P. L. Brubaker, J. Schloos, and D. J. Drucker Regulation of Glucagon-Like Peptide-1 Synthesis and Secretion in the GLUTag Enteroendocrine Cell Line Endocrinology, October 1, 1998; 139(10): 4108 - 4114. [Abstract] [Full Text] [PDF]

				V. Dumoulin, F. Moro, A. Barcelo, T. Dakka, and J.-C. Cuber Peptide YY, Glucagon-Like Peptide-1, and Neurotensin Responses to Luminal Factors in the Isolated Vascularly Perfused Rat Ileum Endocrinology, September 1, 1998; 139(9): 3780 - 3786. [Abstract] [Full Text] [PDF]

				M. Garnier, M. Lamacz, L. Galas, S. Lenglet, M.-C. Tonon, and H. Vaudry Pharmacological and Functional Characterization of Muscarinic Receptors in the Frog Pars Intermedia Endocrinology, August 1, 1998; 139(8): 3525 - 3533. [Abstract] [Full Text] [PDF]

				C. H. Chang, W. Y. Chey, B. Erway, D. H. Coy, and T.-M. Chang Modulation of secretin release by neuropeptides in secretin-producing cells Am J Physiol Gastrointest Liver Physiol, August 1, 1998; 275(2): G192 - G202. [Abstract] [Full Text] [PDF]

				A. B. Damholt, A. M. J. Buchan, and H. Kofod Glucagon-Like-Peptide-1 Secretion from Canine L-Cells Is Increased by Glucose-Dependent-Insulinotropic Peptide but Unaffected by Glucose Endocrinology, April 1, 1998; 139(4): 2085 - 2091. [Abstract] [Full Text] [PDF]

				H. J. Balks, J. J. Holst, A. von zur Muhlen, and G. Brabant Rapid Oscillations in Plasma Glucagon-Like Peptide-1 (GLP-1) in Humans: Cholinergic Control of GLP-1 Secretion via Muscarinic Receptors J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 786 - 790. [Abstract] [Full Text] [PDF]